Â鶹ӳ»­

ARRO 02 - ARRO Annual Resident Seminar (ARRO Day)

11:00 a.m.¨C5:15 p.m.
Room 156/158

Jobs Panel: Career Opportunities and Leadership Outside of the Clinic
Moderator: Rehema Thomas, M.D.

ARRO 03 - ASTRO-ARRO Medical Student Workshop

12:00¨C4:00 p.m.
Room 154

Panel: Shaping Your Path: Academic & Extracurricular Excellence in RadOnc
Panel Speaker: Stephanie Dudzinski, M.D., Ph.D.

PRO 07 - Indolent Lymphomas: Radiation Oncology Considerations

3:45¨C5:00 p.m.
Room 301-304

Talk: Toxicity Reduction Efforts with Radiation Therapy
Presenter: 

SH 12 - Sarcoma and Cutaneous Tumors - Science Highlights

8:00¨C8:30 a.m.
Room 305/306/309

Discussant: 

ASPP 01 - 2025 Aspiring Scientists and Physicians Program

11:00¨C3:00 p.m.
Room 154

Career Pathways Panelist: 

CT 01 - Clinical Trials

1:00¨C2:30 p.m.
San Francisco Ballroom

Discussant:

SS 04 - GYN 1: Molecular and Precision Medicine for Gynecologic Cancers in Diverse Resource Settings

2:30¨C3:45 p.m.
Room 160

Discussant: 

International 02 - Establishing a Global Oncology Program: Overcoming Challenges, Leveraging Opportunities, and Learning from Success

4:45¨C6:00 p.m.
Room 20/21

Talk: Setting Up a Global Oncology Program: Identifying International Partners
Presenter: 

SS 09 - Head and Neck 1: Highest-Rated Abstracts for Virally-Mediated Head and Neck Cancer

4:45¨C6:00 p.m.
Room 305/306/309

Moderator: 

SS 10 - Patient Reported Outcomes/QoL/Survivorship 1: Fixing What's Broken and Reaching for the Sky

4:45¨C6:00 p.m.
Room 314

Moderator: 

Abstract 161: Evaluating the Relationship of Baseline Skin Pigmentation Phenotype on the Evolution of Radiation Dermatitis
Presenter: 

EDU 08 - Radiotherapy for Leukemia: Past, Present and Future

4:45¨C6:00 p.m.
Room 160

Talk: Indications for Radiation Therapy in Leukemia: A Shifting Landscape
Presenter: 

SS 12 - Sarcoma 1: From Margins to Mainstream: Advances in our Understanding of Rare Bone, Cutaneous, and Connective Tissue Tumors

4:45¨C6:00 p.m.
Room 153

Abstract 172: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma Microsatellitosis
Presenter: Kelsey Nordlund

Abstract 173: A Prospective Single-Arm Trial of Postoperative 36 Gy in 10 Fractions for Merkel Cell Carcinoma
Presenter: 

Abstract 175: Surgical Graft and Flap Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma
Presenter: Noel Yang

SS 13 - DHI 1: The Digital Revolution in Radiation Oncology: AI Models for Enhanced Patient Care

8:00¨C9:00 a.m.
Room 20/21

Abstract 178: Crowdsourcing Tumor Auto-Contouring Solutions for MR-Guided Radiotherapy: The HNTS-MRG 2024 Challenge
Presenter: Kareem Wahid, Ph.D.

QP 02 - Nursing and Supportive Care 1: Radiation Oncology Innovation: Fast-Track Insights & Breakthroughs

8:00¨C9:00 a.m.
Room 160

Moderator: Molly Tate, Ph.D.

EDU 20 - ASTRO Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma Guideline: A Case-Based Interactive Discussion

10:45 a.m.¨C12:00 p.m.
Room 307/308

Moderator and Introduction: 

Talk: Target Volumes and Techniques for Definitive EBRT
Presenter: 

SS 17 - Hem 1: Bridging the Gap: Radiotherapy Innovations in Aggressive Lymphomas

10:45 a.m.¨C12:00 p.m.
Room 152

Moderator: 

SS 22 - Radiation and Cancer Physics 2: Imaging Biomarkers for Response Monitoring

10:45 a.m.¨C12:00 p.m.
Room 22/23

Abstract 233: Early Prediction of Radiotherapy Outcome Using ADC Metrics for Head & Neck Squamous Cell Carcinoma
Presenter: Brigid McDonald, Ph.D.

Abstract 235: Unveiling Early Radiation Effects on the Hippocampus: ADC Dynamics Reveal Microstructural Changes during Therapy
Presenter: Ory Haisraely, M.D.

ST 01 - Radiotherapy in Conflict Zones: Stories of Struggles, Resilience and Hope

10:45 a.m.¨C12:00 p.m.
Room 314

Speaker:

PL 01 - Plenary

1:30¨C3:00 p.m.
San Francisco Ballroom

Discussant:

CL 03 - ASTRO Communities Lounge Program - Reclaiming Balance: Evidence-based Strategies for Wellness in Radiation Oncology

3:00¨C4:00 p.m.
ASTRO Communities Lounge

Speaker: 

SS 23 - GU 5: Milestones in Metastatic Prostate Cancer

3:00¨C4:00 p.m.
Room 156/158

Discussant: 

SS 26 - Radiation and Cancer Physics 3: Imaging Development for Planning

3:00¨C4:00 p.m.
Room 155/157

Abstract 255: Changes in High-Grade Glioma Target Volume and Prescription Dose Coverage between Postoperative MRI and MR-Simulation
Presenter: Sara Thower, Ph.D.

Exhibit Hall Networking Reception

4:00¨C5:00
Booth 2137

EDU 32 - ASTRO/SNO Joint Session: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?

5:00¨C6:00 p.m.
Room 160

Talk: Radiation Therapy for Grade 2-3 IDH-mutant Gliomas: Evidence, Innovation, and Evolving Practices
Presenter: 

SS 27 - Breast Cancer 2: Multimodal Strategies in Breast Cancer: Biology, Systemic Therapy, and Psychosocial Insights

5:00¨C6:00 p.m.
Room 156/158

Moderator: 

EDU 31 - Focused Update of ASTRO Rectal Cancer Guidelines: Case-Based Discussion

5:00¨C6:00 p.m.
Room 159

Moderator: 

SS 28 - GU 6: Revelations in Renal Radiotherapy

5:00¨C6:00 p.m.
Room 301-304

Discussant: 

QP 06 - International/Global Oncology 1: Impact of Radiation Techniques and Health System Access in Cancer Mortality

5:00¨C6:00 p.m.
Room 307/308

Moderator: 

SS 29 - Lung 3: NSCLC Early Stage and SBRT

5:00¨C6:00 p.m.
Room 155/157

Abstract 268: Ten-Year Outcomes of the Revised STARS Trial Comparing Radiation and Surgery for Early-Stage Non-Small Cell Lung Cancer
Presenter: Troy Kleber, M.D.

Discussant: 

ST 02 - Radiation Care and Survivorship in the Adolescent and Young Adult Cancer Population

5:00¨C6:00 p.m.
Room 20/21

Moderator, Questions and Answers: 

Talk: Addressing the Gaps: Rising Cancer Rates, Disparities, and Unique Needs in AYA Patients with Cancer
Presenter: Kelsey Corrigan, M.D.

SS 33 - GI 2: Giving Radiation a Boost in Pancreatic Cancer and Responding to the Call for Esophageal Cancer

8:00¨C9:00 a.m.
Room 156/158

Discussant: 

QP 07 - GYN 3: Quick Pitch: Molecular Predictors of Outcomes in Cervical Cancer

8:00¨C9:00 a.m.
Room 159

Moderator: 

EDU 34 - ROBIN Oligometastasis (OligoMET) Center: Using Biomarker Correlates from a Prostate Cancer Clinical Trial to Improve Future Outcomes

8:00¨C9:00 a.m.
Room 154

Speaker:

SS 35 - CNS 3: Spine, Benign, and FLASH: Oh My!

12:45¨C2:00 p.m.
Room 310-312

Abstract 304: Genomic Mutation-Driven Stratification of Treatment Response to Stereotactic Spine Radiosurgery in Spinal Metastases
Presenter: Areeba Al-Sharfeen

QP 10 - DHI 2: Quick Pitch: The Digital Revolution in Radiation Oncology: AI Models for Enhanced Patient Care

12:45¨C2:00 p.m.
Room 20/21

Abstract 1056: Vision-Language AI Model for Detecting PET/CT-Occult Lymph Node Metastasis in Early-Stage NSCLC Treated with SABR to Prevent Regional Recurrence
Presenter: Hui Xu, Ph.D.

EDU 41 - Riding the Waves of New Small Cell Lung Cancer Therapeutics

12:45¨C2:00 p.m.
Room 155/157

Talk: Is There Still a Role for Radiotherapy in Extensive Stage SCLC?
Presenter: 

EDU 42 - The Role of Radiotherapy in Modern Treatment of Endometrial Cancer - The Great Debate

12:45¨C2:00 p.m.
Room 159

Talk: The Role of Radiotherapy in Modern Treatment of Endometrial Cancer - the Great Debate
Presenter: 

LBA 01 - Late Breaking Abstracts

2:30¨C3:45 p.m.
Room 22/23

Abstract LBA 11: Addition of Metastasis-Directed Therapy to Standard of Care: Primary Aggregate Analysis and Immunologic Correlatives of the Phase 2 Randomized EXTEND Trial
Presenter: Alexander Sherry, M.D.

EDU 44 - ASTRO/KCA Joint Session: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate

2:30¨C4:00 p.m.
Room 154

Case Discussions: 

Workshop 04 - Grant Writing Workshop

2:30¨C4:30 p.m.
Room 153

The New NIH Review Criteria and Introductions
Moderator and Presenter: 

Specific Aims
Presenter: 

EDU 46 - Raising the Floor of Oncology Care in the US: Reimagining the Role of Radiation Oncologists

2:30¨C3:45 p.m.
Room 159

Introductions, Questions and Answers: 

SS 43 - Lung 5: Locally Advanced NSCLC: PORT and Cardiac Toxicity

4:00¨C5:00 p.m.
Room 155/157

Moderator: 

EDU 52 - To Radiate or Not Radiate? Updates to Management of Retroperitoneal Sarcoma

4:00¨C5:00 p.m.
Room 160

Talk: Surgical Considerations and Challenges for the Management of Patients with Retroperitoneal Sarcoma
Presenter: 

EDU 55 - The Bioethics of Radiation Oncology: Challenging Clinical Cases

5:15¨C6:15 p.m.
Room 159

Talk: Informed Consent in the Context of Non-disclosure of Cancer Diagnosis
Presenter: 

QP 16 - Head and Neck 5: Quick Pitch: From Fraction to Function: Tailoring Head & Neck Radiotherapy

5:15¨C6:15 p.m.
Room 151

Abstract 1093: A Double-Blinded Analysis of Radiation Dermatitis in Patients with Advanced Oropharyngeal Cancer Treated with IMPT vs. IMRT
Presenter:

QP 19 - GI 4: Quick Pitch: Enhancing Efficacy for Esophageal Cancer and Radiation Responders for Rectal Cancer

8:00¨C9:00 a.m.
Room 154

Abstract 1113: Endoscopic Ultrasound Fine Needle Injection of NBTXR3 Activated by Radiotherapy with Concurrent Chemotherapy for Adenocarcinoma of the Esophagus: Feasibility and Safety of the Phase 1 Dose Escalation Part for the Photon-Based Cohort
Presenter: 

SS 44 - Radiation and Cancer Physics 8: Workflow and On-board Imaging

8:00¨C9:00 a.m.
Room 152

Abstract 355: Toward Advancement of Pediatric Cancer Treatment: A Comparative Study of Pediatric-Specific Models and Adult-Trained Commercial Tools for Radiotherapy Auto-Contouring
Presenter: Sogand Sadeghi, Ph.D.

QP 22 - Radiation and Cancer Physics 9: Motion Management

8:00¨C9:00 a.m.
Room 160

Abstract 1129: Longitudinal Analysis of Log Files from Gated Delivery of Stereotactic Body Radiotherapy Using Motion Management in a 1.5 T MR-Linac
Presenter: Lucas McCullum

QP 24 - Radiation and Cancer Biology 7: Tumor Immune Interactions

10:30¨C11:30 a.m.
Room 159

Abstract 1143: Quantifying pan-cancer immune temperature to predict patient-specific radiation response and outcome
Presenter: Awino Maureiq Ojwang', Ph.D.

SS 46 - Radiation and Cancer Physics 10: Functional and Quantitative Imaging Method Development

10:30¨C11:45 a.m.
Room 152

Abstract 365: Simultaneous T1, T2, T2*, and PDFF Estimation Using Magnetic Resonance Fingerprinting on a 1.5T MR-Linac for Head and Neck Cancer Patients
Presenter: Lucas McCullum

SS 45 - GU 10: Biomarker Breakthroughs in Prostate Cancer

10:30¨C11:45 a.m.
Room 154

Abstract 358: Validation of Six Androgen Production, Uptake and Conversion Genes (APUC-6) in the ECOG-ACRIN E3805 CHAARTED Prostate Cancer Trial
Presenter: